Vital Transformation shared a post on LinkedIn:
“In this episode of the Vital Health Podcast, host Duane Schulthess speaks with two experts on evidence standards for early oncology access at ISPOR Europe 2025 in Glasgow, Scotland:
Oriana Ciani: Associate Professor of Practice at SDA Bocconi
Denis Lacombe: Director General at EORTC – European Organisation for Research and Treatment of Cancer
They discuss why accelerated pathways are used in oncology, what becomes feasible and risky when patient populations are small, how surrogate endpoints such as progression-free survival can differ from overall survival and quality of life, and why post-authorization evidence generation and treatment optimization shape whether early access translates into sustained patient benefit.”
European Organisation for Research and Treatment of Cancer (EORTC) shared Vital Transformation’s post, adding:
“Great to see EORTC CEO, Denis Lacombe, contributing to this important discussion on evidence standards for early oncology access at ISPOR Europe 2025.
Insightful exchange on how we can ensure faster and more sustainable access to effective cancer treatments.”
More posts featuring Vital Transformation.